The KOASTAL-1 study enrolled 383 adult patients with MDD. Navacaprant was shown to be safe and generally well-tolerated with ...

Chime Biologics, a global CDMO, and Mabgeek, a clinical-stage innovative antibody drug development biotech, have successfully ...

Innovent Biologics Inc., a biopharmaceutical company that develops, manufactures and commercializes medicines, has entered a ...

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, has appointed Lori ...

Veeda Group has unveiled a new logo and brand identity— Veeda Lifesciences —reflecting the brand’s evolution from a ...

Demonstrates its commitment to providing quality, cost-saving treatment options to clinicians and the patients they serve.

Averaging up to 20% of weight loss, adults taking Zepbound had 25 fewer breathing interruptions each hour as they slept.

Sangamo plans to explore all options to commercialize the Hemophilia A asset.

Integration of Ori's IRO Platform with Cue and Lovo processing systems aims to enhance efficiency in CGT manufacturing.

Copyright © 2024 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy. The material on ...

Will support the execution of a robust pipeline of customer projects for innovators developing groundbreaking in vivo and ex ...

Novo Nordisk will soon acquire from Novo Holdings Catalent’s three fill-finish sites located in Italy, the U.S., and Belgium.